| Primary |
| Atrial Fibrillation |
23.0% |
| Product Used For Unknown Indication |
18.7% |
| Cerebrovascular Accident Prophylaxis |
18.3% |
| Thrombosis Prophylaxis |
10.7% |
| Deep Vein Thrombosis |
4.9% |
| Knee Arthroplasty |
4.3% |
| Hypertension |
3.6% |
| Pulmonary Embolism |
2.4% |
| Hip Arthroplasty |
2.3% |
| Embolism Venous |
2.2% |
| Ill-defined Disorder |
1.4% |
| Pain |
1.3% |
| Blood Pressure |
1.1% |
| Cardiac Disorder |
1.1% |
| Thrombosis |
1.1% |
| Anticoagulant Therapy |
0.9% |
| Diabetes Mellitus |
0.7% |
| Prophylaxis |
0.7% |
| Orthopedic Procedure |
0.7% |
| Knee Operation |
0.6% |
|
| Pulmonary Embolism |
23.2% |
| Deep Vein Thrombosis |
11.8% |
| Thrombosis |
7.4% |
| Cerebrovascular Accident |
6.8% |
| Gastrointestinal Haemorrhage |
6.7% |
| Haemorrhage |
5.5% |
| Haemorrhage Intracranial |
4.8% |
| Haemoglobin Decreased |
4.1% |
| Drug Ineffective |
3.8% |
| Death |
3.0% |
| Ischaemic Stroke |
2.8% |
| Thrombocytopenia |
2.6% |
| Transient Ischaemic Attack |
2.5% |
| Haematoma |
2.4% |
| International Normalised Ratio Increased |
2.3% |
| Rectal Haemorrhage |
2.2% |
| Subdural Haematoma |
2.0% |
| Cerebral Haemorrhage |
2.0% |
| Renal Impairment |
2.0% |
| Vomiting |
2.0% |
|
| Secondary |
| Atrial Fibrillation |
26.6% |
| Cerebrovascular Accident Prophylaxis |
23.6% |
| Product Used For Unknown Indication |
10.6% |
| Thrombosis Prophylaxis |
10.1% |
| Deep Vein Thrombosis |
5.1% |
| Knee Arthroplasty |
4.3% |
| Embolism Venous |
3.7% |
| Hypertension |
3.3% |
| Pulmonary Embolism |
2.6% |
| Hip Arthroplasty |
2.1% |
| Pain |
1.4% |
| Thrombosis |
1.3% |
| Blood Pressure |
1.0% |
| Cardiac Disorder |
0.8% |
| Anticoagulant Therapy |
0.7% |
| Prophylaxis |
0.7% |
| Diabetes Mellitus |
0.6% |
| Cerebrovascular Accident |
0.5% |
| Blood Cholesterol |
0.5% |
| Cardiac Failure |
0.5% |
|
| Pulmonary Embolism |
20.2% |
| Deep Vein Thrombosis |
11.2% |
| Thrombosis |
7.5% |
| Gastrointestinal Haemorrhage |
6.7% |
| Drug Ineffective |
6.4% |
| Cerebrovascular Accident |
5.6% |
| Haemoglobin Decreased |
4.3% |
| Haemorrhage Intracranial |
3.9% |
| Renal Impairment |
3.6% |
| Thrombocytopenia |
3.4% |
| Ischaemic Stroke |
3.3% |
| Haemorrhage |
3.2% |
| Haematoma |
3.1% |
| Transient Ischaemic Attack |
3.0% |
| Rectal Haemorrhage |
2.6% |
| Subdural Haematoma |
2.5% |
| Melaena |
2.4% |
| Renal Failure Acute |
2.4% |
| Vomiting |
2.4% |
| International Normalised Ratio Increased |
2.2% |
|
| Concomitant |
| Product Used For Unknown Indication |
45.1% |
| Atrial Fibrillation |
10.2% |
| Hypertension |
8.5% |
| Rheumatoid Arthritis |
4.6% |
| Pain |
3.7% |
| Anticoagulant Therapy |
3.1% |
| Diabetes Mellitus |
2.4% |
| Prophylaxis |
2.3% |
| Cardiac Disorder |
2.2% |
| Thrombosis Prophylaxis |
2.2% |
| Cardiac Failure |
2.1% |
| Blood Cholesterol Increased |
2.0% |
| Pulmonary Embolism |
1.9% |
| Deep Vein Thrombosis |
1.6% |
| Depression |
1.5% |
| Asthma |
1.4% |
| Cardiac Failure Chronic |
1.4% |
| Chronic Obstructive Pulmonary Disease |
1.4% |
| Arrhythmia |
1.3% |
| Plasma Cell Myeloma |
1.2% |
|
| Vomiting |
9.2% |
| Thrombosis |
7.9% |
| Renal Failure Acute |
7.2% |
| Weight Decreased |
7.2% |
| Death |
5.9% |
| Pneumonia |
5.9% |
| Hepatitis Acute |
5.3% |
| Nausea |
5.3% |
| Syncope |
5.3% |
| Atrial Fibrillation |
4.6% |
| Pain |
4.6% |
| Pulmonary Embolism |
3.9% |
| Tremor |
3.9% |
| Weight Increased |
3.9% |
| Headache |
3.3% |
| Oedema Peripheral |
3.3% |
| Off Label Use |
3.3% |
| Pruritus |
3.3% |
| Tachycardia |
3.3% |
| Wrist Deformity |
3.3% |
|
| Interacting |
| Atrial Fibrillation |
23.7% |
| Cerebrovascular Accident Prophylaxis |
23.3% |
| Product Used For Unknown Indication |
17.0% |
| Thrombosis Prophylaxis |
5.8% |
| Hypertension |
3.8% |
| Cardiac Disorder |
3.4% |
| Pain |
2.5% |
| Blood Pressure Abnormal |
2.4% |
| Hip Arthroplasty |
2.1% |
| Prophylaxis |
2.0% |
| Anticoagulant Therapy |
1.7% |
| Antiplatelet Therapy |
1.5% |
| Knee Arthroplasty |
1.5% |
| Diuretic Therapy |
1.5% |
| Coronary Artery Disease |
1.4% |
| Diabetes Mellitus |
1.4% |
| Ill-defined Disorder |
1.4% |
| Blood Cholesterol Abnormal |
1.3% |
| Atrial Flutter |
1.2% |
| Stent Placement |
1.2% |
|
| Gastrointestinal Haemorrhage |
16.3% |
| Haemorrhage |
12.4% |
| Rectal Haemorrhage |
6.9% |
| Product Quality Issue |
5.9% |
| Haemoglobin Decreased |
5.4% |
| Haematochezia |
5.0% |
| Haematuria |
4.5% |
| Haemorrhage Intracranial |
4.5% |
| International Normalised Ratio Increased |
4.5% |
| Melaena |
4.5% |
| Subdural Haematoma |
4.0% |
| Blood Urine Present |
3.5% |
| Drug Interaction |
3.0% |
| Inappropriate Schedule Of Drug Administration |
3.0% |
| Occult Blood Positive |
3.0% |
| Prothrombin Time Prolonged |
3.0% |
| Upper Gastrointestinal Haemorrhage |
3.0% |
| Vaginal Haemorrhage |
3.0% |
| Epistaxis |
2.5% |
| Haemoptysis |
2.5% |
|
